by Hamideh Emrani | Feb 10, 2016
Another in the series: “What drives research in the field of biomaterials?” “What makes Canada cool?” asks Dan Taekema of The Toronto Star, and among the handful of influential figures that he writes about is the “rock star” researcher, Professor Molly Shoichet. I was...
by Mark Curtis | Nov 20, 2014
. You have all by now heard that Dendreon has filed for bankruptcy protection. If you’re a regular reader of Signals, you may have first heard the news here. While the company has successfully reached agreements on a financial restructuring with a majority of its...
by Natasha Davie | May 16, 2013
We live in a time of extraordinary medical advances. So far in 2013, we’ve seen the successful transplantation of a bioengineered kidney into rats, an infant reportedly cured of HIV using anti-retroviral drugs that are currently on the market, and discovered a protein...
by Lisa Willemse | Feb 1, 2012
Some updates and news items of note: Call for boycott of subscriber-based journals gains momentum The ongoing friction between proponents of open access and the academic publishers has jumped into the spotlight once again with calls from a number of academics, most...
by David Kent | Nov 17, 2011
While many researchers will feel disheartened by last month’s ruling in the Court of Justice of the European Union that prohibits scientific research patents on human embryonic stem cell products (see Ubaka Ogbogu’s article), it seems some positive news is emerging...
Comments